Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Strides Pharma Inc., priced at $0.6950 per EA under NDC 64380079701. Its NADAC has been published 406 times since Nov 14, 2018.
FDA first approved this application on Jun 8, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380079701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209421FDA Approved
6/8/2018
TE Code
AB
On Market Since
10/8/2018
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 406 times since Nov 14, 2018, and over the history we have for it it has declined 91.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6950 per EA |
|---|---|
| All-time high | $8.0326 (Nov 14, 2018) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $1.4304 |
| Average price | $2.2826 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 406 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Strides Pharma Inc., is $0.6950 per EA (NDC 64380079701), effective Aug 19, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 91.3%. It has been tracked across 406 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Nov 14, 2018, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.0326 (Nov 14, 2018), with a median of $1.4304 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 64380079701) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.